- Home
- ROIV vs XP Comparison
ROIV vs XP Comparison
Compare ROIV & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | XP |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United Kingdom | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 10.1B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ROIV | XP |
|---|---|---|
| Price | $28.05 | $18.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $27.56 | $22.67 |
| AVG Volume (30 Days) | 4.8M | ★ 6.2M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $19.15 |
| Revenue Next Year | $385.85 | $13.67 |
| P/E Ratio | ★ N/A | $11.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $12.20 |
| 52 Week High | $30.33 | $23.13 |
Technical Indicators
Market Signals| Indicator | ROIV | XP |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 39.43 |
| Support Level | $26.94 | $18.05 |
| Resistance Level | N/A | $20.37 |
| Average True Range (ATR) | 1.01 | 0.95 |
| MACD | -0.21 | -0.42 |
| Stochastic Oscillator | 32.70 | 0.93 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.